000 01278 a2200361 4500
005 20250515182546.0
264 0 _c20091124
008 200911s 0 0 eng d
022 _a1744-7666
024 7 _a10.1517/14656560903140525
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDuh, Mei Sheng
245 0 0 _aThe economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
_h[electronic resource]
260 _bExpert opinion on pharmacotherapy
_cOct 2009
300 _a2317-28 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Review
650 0 4 _aAnticonvulsants
_xeconomics
650 0 4 _aCanada
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDrugs, Generic
_xeconomics
650 0 4 _aEpilepsy
_xdrug therapy
650 0 4 _aHealth Care Costs
650 0 4 _aHumans
650 0 4 _aTherapeutic Equivalency
650 0 4 _aTreatment Outcome
650 0 4 _aUnited States
700 1 _aCahill, Kevin E
700 1 _aParadis, Pierre Emmanuel
700 1 _aCremieux, Pierre Y
700 1 _aGreenberg, Paul E
773 0 _tExpert opinion on pharmacotherapy
_gvol. 10
_gno. 14
_gp. 2317-28
856 4 0 _uhttps://doi.org/10.1517/14656560903140525
_zAvailable from publisher's website
999 _c19070151
_d19070151